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Abstract
Background: Public awareness and engagement are among the main prerequisites for protecting the rights of
research participants and for successful and sustainable functioning of research biobanks. The aim of our study was
to analyse public awareness and attitudes towards research biobanks in Latvia, and to compare these data with the
results of the 2010 Eurobarometer study. We also analysed the influence of awareness and attitudes towards
biobanks on willingness to participate in biobank studies and on preferred type of informed consent.
Methods: We developed a 12-question survey repeating seven questions about biobanks from the 2010
Eurobarometer questionnaire and adding five others. After describing the study variables, we performed a two-
stage analysis of the results. In the first stage we analysed differences between the answers from 2010 and 2019
and conducted univariate analyses of relationships among particular variables, and between those variables and the
socio-demographic characteristics of participants. In the second stage we investigated multivariable associations of
willingness to participate and type of consent with awareness, trust and the socio-economic characteristics of
participants.
Results: According to our study, the general public in Latvia is still not well informed about research biobanks.
Fewer respondents have heard about research biobanks than in 2010. At the same time, the number of
respondents who are willing to donate biological samples and personal data to a biobank has increased, e.g. the
number of respondents who would definitely or probably be willing to provide information about themselves has
increased from 25.8.% to 40.7 since 2010. Overall, concerns about the donation of different types of biological
samples and data to a biobank have slightly decreased.
Conclusions: Public awareness about biobanks is important for their sustainability. It needs to be increased not
only by traditional methods of informing the public, but also by more innovative and participatory approaches, e.g.
by citizen science projects. There is a need to strengthen the public visibility and trustworthiness of ethics
committees in Latvia in the field of biobanking.
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Background
Latvia is a European Union (EU) member state with
several actively functioning research biobanks. The
oldest and one of the most active is the national Gen-
ome Database of Latvian Population established in
2003 and currently storing biological samples from
more than 35,000 donors (Latvia had 1,919,968 resi-
dents in 2019). The national biobank community
faces the need to integrate the national network of
biobanks in the European Research Area to promote
international collaboration in biomedical research.
The integration process started when Latvia was ap-
proved as a member of the Biobanking and Biomolec-
ular Resources Research Infrastructure (BBMRI-ERIC)
in 2016. In 2018, Latvia signed the declaration “To-
wards access to at least one million sequenced ge-
nomes in the European Union by 2022”, which aims
to link genomic health data throughout the EU [1]. In
general, Latvia has most of the prerequisites for fur-
ther development of research biobanking: human re-
sources, knowledge capital, infrastructure and national
network of biobanks. At the same time, there are sig-
nificant gaps in existing legal frameworks and state
policies that prevent the successful functioning of bio-
banks, and only one biobank – the Genome Database
of Latvian Population - is clearly regulated by the law
[2]. Additionally, there are basic national regulations
defining the standards for collection, storage, use and
transfer of biological samples of human origin for use
in biomedical research; however, most of the laws
and regulations in force were developed more than
15 years ago and do not meet current international
standards. An appropriate solution would be to
strengthen the legal framework in Latvia by adopting
a new law on biobanks, and a national working group
established by the Latvian National Node coordinating
BBMRI-ERIC activities has started the process of
drafting a new Biobank law. Also, the research ethics
committee system still needs improvements regarding
transparency and procedural clarity of ethical review,
conflicts of interest management, composition of
committees and motivation of their members [3].
Public awareness and engagement are among the main
prerequisites for protecting the rights of research partici-
pants, developing new regulations, and for successful and
sustainable functioning of research biobanks [4]. Budin-
Ljøsne et al. in their analysis of ethical, legal and social issues
in the context of national biobank infrastructures include
“lack of knowledge surrounding biobank research among the
general public” and “lack of public debate” among the major
social/political challenges, and suggest organising public for-
ums and informing society as strategies to address those
challenges [5]. The World Medical Association (WMA) Dec-
laration of Taipei emphasises transparency, participation,
inclusion and accountability among the principles of biobank
governance, fostering the trustworthiness of biobanks [6].
Implementation of these principles cannot be one-sided; it
requires all stakeholders, including the general public, to be-
come involved. Therefore, analysis of public opinion by
measuring public awareness, attitudes and willingness to par-
ticipate is very important for giving the public a voice in de-
bates. However, it does not substitute for more participatory
methods of public engagement.
In 2010, a pan-European Eurobarometer survey of Life
Sciences and Biotechnology included a set of questions
on public attitudes towards biobanks [7]. The survey was
conducted in February 2010 and used multi-stage prob-
ability sampling to obtain representative samples in each
EU member state as well as Croatia, Iceland, Norway,
Switzerland and Turkey [8] (ca.1000 respondents in each
country; 1013 in Latvia). The questions on biobanks
“were administered to half of the sample in each country
through a randomised split ballot” [8]. The findings of
this study showed that “the publics of Europe are hetero-
geneous in their response to biobanks” [8]; people in
Eastern and Southern Europe were less willing to partici-
pate in research biobanks and preferred narrow (specific)
consent [8]. The low willingness to participate in bio-
banks in Latvia as shown by this 2010 Eurobarometer
study may be at least partially explained by the general
level of trust in science in the country which in 2010
was lower than average in the EU [9].
These 2010 findings, and a small qualitative interview
study on donors’ attitudes towards the Genome Database
of Latvian Population [10], have been the only data on
public attitudes towards biobanks in Latvia so far. To fill
this knowledge gap in the context of developing the new
Biobank law, we decided to analyse public attitudes by
conducting a survey repeating the 2010 Eurobarometer
survey questions on biobanks [7]. We added questions on
awareness of the Genome Database of Latvian Population,
willingness to donate specific types of biological samples,
and preferred types of consent for donation of surplus sur-
gical material, to the 2010 questions. The aim of our study
was to analyse public awareness and attitudes towards re-
search biobanks in Latvia, and to compare these data with
the results of the 2010 Eurobarometer study. We also ana-
lysed the influence of awareness and attitudes towards
biobanks on willingness to participate in biobank studies
and preferred type of informed consent on the basis of the
new 2019 survey data.
Methods
A 12-question quantitative survey was developed by the
panel of six authors. The survey included all seven ques-
tions on biobanks and the introductory explanation of
the term ‘biobank’ from the 2010 Eurobarometer ques-
tionnaire (question numbers B12-B18 in that original
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questionnaire), which together with its translations and
data is available in open access on the GESIS archive
[11]. The 2010 translations of the Eurobarometer ques-
tionnaire into Latvian and Russian were used for the 2019
survey. Five additional questions on willingness to donate
specific types of biological samples (blood, surplus surgical
material, urine, faeces), opt-out consent for biobanking
surplus surgical material, and two questions on awareness
about the Genome Database of Latvian Population were
added to the 2019 survey by the research group.
Our 2019 survey was conducted in March 2019 and
used multi-stage stratified random sampling to obtain a
representative sample of the general population of
Latvia. Data were collected by the research centre SKDS
as part of the monthly Omnibus survey by conducting
face-to-face interviews in the respondents’ homes. The
sample comprised Latvian residents aged 18 to 75 years.
Sample design was based on the latest statistics on per-
manent residents of Latvia.
Awareness and willingness to participate
Awareness of biobanks in the 2010 Eurobarometer sur-
vey was assessed by answers to three questions: (1) Be-
fore today, have you ever heard anything about
biobanks? (2) Have you ever talked about biobanks with
anyone before today? (3) Have you ever searched for in-
formation about biobanks? These questions were then
combined to create the next levels of categories: (a) pas-
sive engagement (heard but not talked or searched for
information), (b) active engagement (heard and talked or
searched for information), and (c) not heard. In addition
to those three questions, we included two new questions
concerning the Genome Database of Latvian Population
in the 2019 survey: (1) Have you ever heard anything
about the Genome Database of Latvian Population? with
answers ‘yes’, ‘no’ and ‘difficult to say’; (2) How would
you rate the work of the Genome Database of Latvian
Population?, where the possible answers were ‘in favour
of the idea’, ‘wait-and-see attitude’, ‘need more informa-
tion’, ‘never heard’, ‘against it’, and ‘cannot comment’.
Willingness to participate in biobank studies was mea-
sured by the 2010 Eurobarometer survey question: Would
you be willing to provide information about yourself to a
biobank? and the possible answers were: ‘yes, definitely’,
‘yes, probably’, ‘no, probably not’, ‘no, definitely not’.
These answers were combined for analysis into two more
general ‘yes’ and ‘no’ categories. In addition to this ques-
tion from the 2010 questionnaire, we added a question
about participants’ willingness to donate specific types of
biological material to a biobank in 2019: Would you agree
to including the following samples of your biological mater-
ial into a biobank? mentioning ‘blood’, ‘surplus surgical
material’, ‘urine’ and ‘faeces’ as types of biological material
and providing ‘yes’, ‘no’, ‘do not know’ as possible answers
for each type. As each participant could choose multiple
answers for this question, we descriptively analysed the
answers about each type of biological samples individually.
Informed consent
To explore the opinions of respondents about the type of
informed consent we used two Eurobarometer 2010 ques-
tions: (1) When a scientist does research on data in a bio-
bank, what do you think about the need for this kind of
permission? (there was an explanation of the term ‘in-
formed consent’ before this question), and the possible an-
swers were: ‘no need to ask for permission’, ‘ask for
permission only once’, ‘ask for permission for every new
piece of research’. For statistical analysis, this question was
re-coded into two categories: (a) broad consent (‘no need
to ask permission’ or ‘ask only once’) and (b) narrow con-
sent (‘ask for permission for every new piece of research’).
The second question was: (2) Would you agree that your
surplus surgical material would be included in a biobank
without your consent, if you would not specifically prohibit
it? suggesting four options of answers: ‘yes, definitely’, ‘yes,
probably’, ‘no, probably not’, ‘no, definitely not’. Answers
on this question were dichotomised for analysis into two
types: (a) yes/opt-out and (b) no/opt-in.
Concerns
To investigate participants’ concerns about the collec-
tion of their data and samples for a research biobank, we
used answers to a Eurobarometer 2010 question: Would
you personally be concerned or reluctant about the col-
lection of any of the following types of data and materials
from you? As the participants could choose multiple an-
swers to this question, we performed descriptive statis-
tics for each of the yes/no answers for blood samples;
tissue collected during medical operations; genetic pro-
file; medical records; and lifestyle.
Governance and trust
To investigate participants’ trust and attitudes towards
governance of research biobanks we used two Euroba-
rometer 2010 questions: (1) Who do you think should be
primarily responsible for protecting the public interest?
and (2) Do you think the sharing and exchange of per-
sonal data and biological materials across Member
States should be encouraged? For the question on re-
sponsibility, descriptive statistics for primary and sec-
ondary responsibility was performed. For the question
on sharing samples across EU, we dichotomised the an-
swers (‘yes, definitely’, ‘yes, probably’, ‘no, probably not’,
‘no, definitely not’) into yes/no groups.
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Statistical analysis
Descriptive statistics was performed for all study var-
iables. Variables, numbers and percentages were pre-
sented for categorical variables. For qualitative
variables, mean and standard deviation were pre-
sented if the variable was normally distributed, and
median and interquartile range otherwise.
After description of study variables, we analysed our re-
sults in two stages. In the first stage, we analysed differ-
ences between the answers from 2010 and 2019 for the
following 2019 survey answers: awareness of research bio-
banks, willingness to participate, opinions regarding the
type of informed consent, concerns regarding donation of
samples and data, and governance and trust. We per-
formed univariate analyses of the relationships among
these variables by themselves, and between these variables
and the socio-demographic characteristics of participants.
In the second stage, we investigated multivariable associations
of willingness to participate and type of consent with awareness,
trust and the socio-economic parameters of participants for the
2019 data. As in the 2010 Eurobarometer survey [8], for the
2019 survey we built multivariable logistic regression models to
determine the role of awareness and trust in predicting the odds
of being willing to donate samples and data to a biobank and
preferring broad consent over narrow consent. To measure
awareness in these models, we combined the answers to the
questions on awareness and searching for information - ‘passive
engagement’, ‘active engagement’, and ‘not heard’. For trust, we
used the question on sharing the information across EU Mem-
ber States (dichotomous variable, yes/no). All models were ad-
justed for participant age, years of education, and gender. SPSS
software, v. 26, was used for statistical analyses. P values < 0.05
were considered statistically significant.
Results
Demographic characteristics of the respondents
One thousand and seventeen respondents participated in
our survey (N = 1017). Their mean age was 46.3 years
(standard deviation, SD = 15.8). Slightly more women
than men participated, and most of the participants were
married, with secondary or professional education, and
were native Latvians. Most earned less than 210 Euro
per month per person in the family (median 301–400
Euro), had no children, worked in the private sector and
lived in cities outside the capital (Table 1). There were
no significant differences between the participants in the
Eurobarometer 2010 and our 2019 surveys in respect of
gender or marital status, but the 2019 participants were
significantly older, with fewer living in rural areas, and
with more Russian speakers (Supplement Table 1).
Awareness and willingness to participate
In 2019, 262 (25.8%) of the 1017 participants in the
study said they had heard about biobanks. Among those,
100 (38.2%) were actively engaged in searching informa-
tion on biobanks, but the others (N = 162) were not.
One hundred and ninety-six participants (19.2%) said
they have heard about the Genome Database of Latvian
Population. Most of them stated that they ‘need more
information’ to rate the work of the Genome Database
of Latvian Population (N = 61, 6.0%), or are ‘in favour of
the idea” (N = 58, 5.7%) or have a ‘wait-and-see attitude’
(N = 53, 5.2%). Only one person was definitely against
this project (0.1%), and a further 23 (2.3%) had no opin-
ion or did not answer this question.
Awareness of biobanks in the 2019 survey was signifi-
cantly related to the education and income of partici-
pants, their residential status and place of work.
Participants who lacked awareness were of lower educa-
tional level, and only one participant with primary edu-
cation was actively engaged in searching information
about biobanks. There was no difference in active and
passive engagement between those whose average salary
per month per family member was over 590 Euro, but
they were more engaged, both passively and actively,
than participants with lower salaries. Those participants
with lower salaries were more likely to be actively than
passively engaged. More Latvian citizens than Latvian
non-citizens were aware of biobanks, and more Latvian
citizens were actively engaged (Supplement Table 2).
Among all participants in the 2019 survey, 373 (36.7%)
would definitely (N = 67; 6.6%) or probably (N = 306;
30.1%) be willing to provide information about them-
selves to a biobank, while 544 (53.5%) would not be will-
ing to do so (of those, N = 250 (24.5%) were definitely
not willing to provide information). One hundred partic-
ipants (9.8%) did not answer this question. We observed
differences in willingness to participate with all socio-
demographic variables excluding gender, education, and
having children under the age of 18. Participants who
were willing to participate in biobank research by shar-
ing their information with a biobank were younger, most
of them earned more than 590 Euro per month per one
family member, and more were native Latvians with Lat-
vian citizenship (Supplement Table 3).
Among all 2019 survey participants, 462 (45.4%) were
willing to donate blood samples to a biobank; 409 (40.2%)
to provide surplus surgical material; 430 (42.2%) to donate
urine samples; and 411 (40.4%) to donate faeces samples.
Informed consent
Broad consent for donation of biological samples to a
biobank was preferred by only 27.4% of all partici-
pants; 62.2% preferred narrow consent; 105 (10.3%)
had no opinion on this question. Opinions regarding
the type of informed consent were related to partici-
pants’ education (more people with higher education
chose broad consent), income (more people with
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higher income preferred broad consent) and place of
residence (Supplement Table 4).
An opt-out approach for surplus surgical material
was approved by 39.3% of participants, while more re-
spondents would prefer an opt-in form of informed
consent for samples of this type (53.1%). Opt-out use
of surplus surgical material was related to education
(more people with higher education would allow such
use), residential status, working status, and place of
residence (most respondents from cities other than
the capital preferred not to allow use) (Supplement
Table 5).
Most of the participants (59.6%) agreed to sharing of per-
sonal data and biological samples across EU Member States
(21.2% were definitely sure about it); 19.0% found it difficult
to answer this question. A positive attitude towards sharing
of biobank samples among EU states was related to marital
status, average salary, residential status, and place of living
(Supplement Table 6).
Biobank-related opinions and socio-economic status of
survey participants
All investigated biobank-related parameters were uni-
variately related to average monthly salary and place of
residence. Participants with higher salaries were more
aware of biobanks, more willing to participate, less open
to using broad consent, but more willing to share data
and samples among EU member states. Those living in
small cities were more aware of biobanks, less willing to
participate, preferred narrow consent, were less in favour
of opt-out use of surplus surgical material, and were less
willing than the other two groups to share data and sam-
ples among EU member states (Supplement Tables 1–6).
Table 1 Socio-demographic characteristics of respondents
Variable Category 2019 results
Gender (N, %) Male 480 (47.2)
Female 537 (52.8)
Age, median (mean ± SD) 46.0 (46.3 ± 15.8)




Education (N, %) Primary 116 (11.4)
Secondary/ professional 631 (62.0)
Higher 270 (26.5)




> 591 179 (20.1)
Having children under the age of 18 (N, %) 348 (34.2)
Nationality (N, %) Latvian 601 (59.1)
Russian 327 (32.2)
Other 89 (8.8)
Residential status (N, %) Latvian citizen 873 (85.8)
Latvian non-citizena 144 (14.2)
Working status (N, %) Governmental sector 195 (19.2)
Private sector 455 (44.7)
Not working 367 (36.1)
Place of residence (N, %) Capital city 335 (32.9)
Another city 385 (37.9)
Rural area 297 (29.2)
a‘Non-citizens’ is a special legal status established in 1991 for former USSR citizens permanently residing in Latvia without the citizenship of the Republic of Latvia
or any other country
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Additional differences were observed among participants
with different educational levels and working status. More
educated participants were more aware of biobanks (both
passively and actively), and more agreed to opt-out use of
surplus surgical material (Supplement Tables 2 and 5).
There were no differences among participants in respect of
level of education in their willingness to participate, type of
preferred consent (broad versus narrow) or willingness to
share data and samples among EU member states (Supple-
ment Tables 3, 4 and 6). Those participants who worked
were more aware of biobanks, more willing to participate,
and more willing to accept the opt-out use of surplus surgi-
cal material (Supplement Tables 2, 3, 5). There were no dif-
ferences related to working status in the type of preferred
consent or willingness to share data and samples among
EU member states (Supplement Tables 4 and 6).
There was a relationship between awareness of bio-
banks and engagement and willingness to participate
(p < 0.01). Those who were actively engaged were more
willing to participate. We also observed a relationship
between willingness to participate and the preferred
form of consent (p < 0.01) (Table 2).
Concerns
Most participants had no concerns regarding donation of
their biological samples and personal data to a biobank.
This applied to all types of biological material mentioned
in the question, and to personal data (Table 3).
Governance and trust
When they answered the question about stakeholders re-
sponsible for protecting the public interest in the con-
text of biobank research, most participants agreed that
the first responsible group are medical doctors, and the
second are researchers. For almost 16% of the partici-
pants it was difficult to decide about the first and second
responsible stakeholder (Table 4).
Differences between results of 2010 and 2019 surveys
There were statistically significant differences between
results of the 2010 and 2019 surveys regarding aware-
ness of biobanks, willingness to participate, type of con-
sent, and sharing data and samples among EU member
states (Table 5). In 2019, more participants had not
heard about biobanks, but among those who had heard
about biobanks in 2010 and 2019 there were no differ-
ences in passive and active engagement (p = 0.39). In
2019, more participants were willing to participate, pre-
ferred broad consent, and were positive about sharing
data and samples among EU member states (Table 5).
Multivariate analysis
In fully adjusted multivariable regression models of the
2019 survey results, willingness to participate was signifi-
cantly associated with awareness, trust and age (adjusted
R2 = 17.8) (Fig. 1, Supplement Table 7). Passive aware-
ness (odds ratio, OR = 0.52 [95% confidence interval, CI
0.28, 0.96]), absence of trust (OR = 0.21 [CI 0.10; 0.44]),
and older age (OR = 0.97 [CI 0.95; 0.99]) reduced will-
ingness to participate. No other investigated factors were
associated with willingness to participate.
We found no significant association between preferred
type of informed consent and any socio-demographic factor
(Fig. 2, Supplement Table 8). However, the overall tendency
remains as in the previous regression model and all factors
except secondary/professional education were in the same
direction. Absence of trust reduced non-significantly a
probability for broad consent (OR = 0.54 [0.27; 1.08]). Age
did not affect this probability but remains in the same dir-
ection as in the previous model (OR = 0.99 [0.97; 1.01]).
Discussion
According to our study, the general public in Latvia is still
not well informed about research biobanks. The number
of respondents who have heard about research biobanks is
less than in 2010. However, more respondents are willing
to donate biological samples and personal data to a bio-
bank, e.g. the number of respondents who would definitely
or probably be willing to provide information about them-
selves to a biobank has increased from 25.8.% to 40.7 since
2010. Overall, concerns about the donation of different
types of biological samples and data to a biobank have
slightly decreased, but the greatest concern remains the
use of data from patients’ medical records.
A recent literature review [4] and studies in other
European countries also show willingness to donate
samples and information to biobanks despite low
Table 2 Relationship between willingness to participate, awareness, engagement, and the preferred form of consent
Willingness to participate P
valueYes No
Awareness Passively engaged, N = 153 76 (49.7) 77 (50.3) < 0.01
Actively engaged, N = 95 64 (67.4) 31 (32.6)
Not heard, N = 669 232 (34.7) 437 (65.3)
Type of consent Broad, N = 259 157 (60.6) 102 (39.4) < 0.01
Narrow, N = 575 203 (35.3) 372 (64.7)
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awareness of them. In a regional study conducted in
Germany in 2015 the respondents showed high overall
support for biobanks, e.g., “70.4% of respondents would
be willing to donate biomaterial to a biobank during a
hypothetical stay in hospital”; however, only about one
third (30.8%) had previously heard of biobanks, and this
level of awareness had not changed since the 2010 Euro-
barometer study [12].
At the same time, rising awareness is not a panacea
for promoting willingness to donate samples and per-
sonal data. The relationship between high levels of
awareness, positive attitudes and real participation rates
in biobanks is not direct. As emphasised by Snell and
Tarkkala in their analysis of the rhetoric of a ‘willing
population’ in Finnish biobanking: “supporting and posi-
tive attitudes or high levels of general trust in a given so-
ciety are not in themselves straightforward indications of
people’s actual willingness and preparedness to partici-
pate in biobanking” [13]. Such criticisms highlight the
need to seek new ways of promoting the values of trans-
parency, participation, inclusion and accountability and of
overcoming the risk of instrumentalisation of donors by
looking at potential donors as just a resource providing
samples and personal data to a biobank or passive objects
of research requiring protection. One possible solution
suggested by Langhof et al. is that biobanks should “con-
centrate on how to balance the different interests of pa-
tients/donors, (public) funding agencies, clinician/
researcher collecting, and biobank staff processing and
storing human biological materials and, thus, acting as
stewards of the hosted biosamples” [14]. However, this ap-
proach, which involves stakeholders but still nominates
scientists as the main responsible stewards of samples and
data, could be outdated in the context of biobanking. As
shown in other fields of science, e.g. management of open
data [15] or environmental science [16, 17], broader un-
derstanding of stewardship moving towards active engage-
ment of stakeholders can be highly beneficial, allowing
researchers to focus on the needs of the public and com-
munities and to avoid instrumentalising attitudes. Another
approach suggested by Gottweis et al. is “to create some
sort of expert publics, i.e., publics composed of people
who are well informed about a certain issue at stake” [18].
This approach might be combined with previously men-
tioned broader understanding of stewardship to build new
forms of collaborative biobank governance.
The ongoing process of development of the new Bio-
bank law in Latvia includes public consultations with
stakeholders (general public, scientists, industry, non-
governmental organizations etc); however involvement
of and collaboration with stakeholders can be made even
more active by implementing community-based partici-
patory research methods and citizen science approaches
for choosing research priorities and involving donors
more actively in the biobanking process. Recent studies
demonstrate various participatory approaches, e.g.
methods for improving informed consent [19], wiki-
governance models [20], citizen science in the form of
personal genome projects [21], and many other methods,
opening a promising new perspective on biobanking.
Some recent examples of biobank-based participatory re-
search show “enthusiastic response for ‘taking part’ and
‘being listened to’” [22] and raise the hope that “citizen
science applications and participatory research and gov-
ernance strategies could lead into a novel area to explore
for the field” [23]. As emphasised by Tupasela et al., by
using participatory models, “increased participation also
increases the flow of information in both directions, as
opposed to being top-down in nature” [24]. Although
Table 4 Stakeholders responsible for protecting public interests
Responsible stakeholder First responsibility (N, %) Second responsibility (N, %)
Medical doctors 293 (28.8) 144 (14.1)
Researchers 158 (15.6) 219 (21.6)
Public institutions (universities, hospitals) 36 (3.6) 73 (7.2)
National governments 130 (12.7) 97 (9.6)
Ethics committees 26 (2.5) 45 (4.4)
International organisations such as the EU or WHO 76 (7.5) 80 (7.9)
National Data Protection Authorities 155 (15.2) 172 (16.9)
Difficult to say 121 (11.9) 39 (3.8)
Table 3 Concerns about donation of biological samples and
data to biobanks
Materials for biobanks Concerns, n = 1017
No (N, %) Yes (N, %)
Blood samples 758 (74.5) 259 (25.5)
Tissue collected during medical operations 745 (73.3) 272 (26.7)
Genetic profile 738 (72.5) 279 (27.5)
Medical records 655 (64.4) 362 (35.6)
Lifestyle information 755 (74.2) 262 (25.8)
Other 968 (95.1) 49 (4.9)
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some critical views indicate that most public members
have “neither the time nor the interest to become in-
volved in participatory structures of biobank designs”
[18] and genuine participation seems more rhetoric than
reality [25], the existing examples are promising, espe-
cially if the central participatory elements (being educa-
tional, promoting a sense of being involved and degree
of control [25]) are respected.
The preferred and ethically most justifiable type of in-
formed consent remains one of the most discussed eth-
ical issues in the context of biobanking. The
‘communitarian turn’ in bioethics, and the ethics of bio-
banking in particular [26, 27], emphasised the
importance of broad consent and solidarity for maximis-
ing public benefit in the context of biobanking. In Latvia,
biobanks currently use broad consent for a wide range
of unspecified future research including an option to re-
strict particular types of sample use. However, the re-
sults of our survey show that most respondents still
prefer narrow consent, providing information about each
particular research study where the donor’s samples are
used. A possible solution could be to introduce dynamic
consent, “a digital decision-support where modern IT
communication strategies are used to continuously in-
form and offer choices to donors to specify the types of
research for which their specimens can be used or not”
Fig. 1 Association of willingness to participate in biobank with awareness, trust and socio-demographic factors – results of logistic regression
model (ORs are presented at logarithmic scale)
Table 5 Differences between 2010 and 2019 survey results.
Variable Category 2010 survey 2019 survey P value
Awareness, N (%) Passively engaged 134 (27.6) 162 (15.9) < 0.01
Actively engaged 87 (17.9) 98 (9.6)
Not heard 265 (54.5) 757 (74.4)
Willingness to participate, N (%) Yes 117 (25.8) 373 (40.7) < 0.01
No 337 (74.2) 544 (59.3)
Type of consent, N (%) Broad 88 (20.2) 279 (30.6) < 0.01
Narrow 347 (79.8) 632 (69.4)
Sharing of data and samples within EU, N (%) Yes 248 (59.8) 606 (73.5) < 0.01
No 167 (40.2) 218 (26.5)
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[4]. However implementation of this type of consent in
Latvia is limited by the financial recourses of biobanks.
Some authors also warn about risks that use of dynamic
consent based on digital technologies could lead to
deepening the ‘digital divide’ by favouring those “with
knowledge and access to digital technologies” [28],
which in turn could lead to negative effects and decrease
participant engagement in research. Therefore, it is im-
portant to look for solutions likely to improve partici-
pant inclusivity and to evaluate empirically how dynamic
consent tools will affect equality in access to research
participation [28].
We should admit that our study has some limitations
related to the sample. Compared to the 2010 Euroba-
rometer study sample there are slight differences in the
respondents’ ages, which could affect comparisons of the
results since younger people are likely to be more aware
of biobanks. Similarly, slightly more residents of rural
areas were included in the 2019 sample, and this could
also have affected the results of our study.
Conclusions
In comparison with 2010, there is less awareness of re-
search biobanks among the general public in Latvia, but
the public is slightly more willing to participate in
research biobanks by donating biological samples and
personal data. Younger people with higher educational
levels who are more engaged in searching information
about biobanks are more willing to donate samples. This
shows a need to inform a broader public including the
older generation and people in rural areas about the role
of research biobanks. Public awareness about biobanks is
important for their sustainability and it needs to be in-
creased not only by traditional methods of informing the
public, but also by more innovative and participatory ap-
proaches, e.g. by citizen science projects. Biobanks
should not only promote donors’ awareness, but also in-
crease willingness to donate material and to engage in
biobank-based research by active participation. More in-
formation on biobanks and biobank-based research
should be made available to the public in Latvia to dem-
onstrate the results and benefits of donations.
Another important issue is responsibility for protect-
ing the public interest. Most respondents in our survey
chose physicians and scientists as responsible actors for
protecting public interest in the field of biobanks. Re-
searchers and physicians were also the groups most
trusted across Europe in the 2010 Eurobarometer survey
[7]. The main responsibility in our 2019 survey was at-
tributed to individual doctors and scientists, not to the
Fig. 2 Association of preferred type of informed consent (broad over narrow) with awareness, trust and socio-demographic factors – results of
logistic regression model (ORs are presented at logarithmic scale)
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institutions for which they work or other institutions
such as ethics committees or governmental bodies. The
attribution of responsibility to scientists has reduced
since 2010, but the attribution of responsibility to na-
tional data protection authorities has significantly in-
creased, which can most likely be explained by the
introduction of General Data Protection Regulation and
the public discussions surrounding this process. These
results show a lack of information about or trust in re-
search ethics committees in Latvia, which needs clarifi-
cation by further research and a discussion about
possible ways of strengthening the role of ethics com-
mittees in the context of development of the new Bio-
bank law. Currently, the public in Latvia sees doctors and
scientists as the main responsible and trustworthy actors
for protecting public interest, but the public either does
not trust research ethics committees or is not aware on
their role in protecting public interests. There is a need to
strengthen the public visibility and trustworthiness of eth-
ics committees in Latvia in the field of biobanking.
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